Legato Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,605
Closed -$578K 586
2023
Q3
$578K Buy
+8,605
New +$592K 0.08% 363
2018
Q1
Sell
-33,652
Closed -$1.32M 146
2017
Q4
$1.32M Sell
33,652
-7,607
-18% -$289K 0.19% 129
2017
Q3
$1.52M Buy
41,259
+18,379
+80% +$655K 0.23% 117
2017
Q2
$881K Buy
22,880
+21,124
+1,203% +$773K 0.38% 73
2017
Q1
$60K Buy
1,756
+440
+33% +$14.4K 0.07% 53
2016
Q4
$43.2K Buy
+1,316
New +$42.7K 0.78% 66

Other funds holding EHC

Legato Capital Management's EHC Position: Q4 2023 in Review

Legato Capital Management sold out of Encompass Health (EHC) in Q4 2023, closing a stake of 8,605 shares — an estimated $578K sold.

Legato Capital Management first reported a position in EHC in Q4 2016 and held it in 6 quarters. The position peaked at $1.52M in Q3 2017. 435 funds tracked by Wall St. Rank hold EHC as of Q4 2023.

  • Legato Capital Management reported no remaining Encompass Health position as of Q4 2023 after selling out during the quarter.
  • Legato Capital Management sold 8,605 Encompass Health shares in Q4 2023, an estimated $578K.
  • Legato Capital Management first reported a position in Encompass Health in Q4 2016 and held it in 6 quarters.
  • Legato Capital Management's Encompass Health position peaked at $1.52M in Q3 2017.
  • 435 funds tracked by Wall St. Rank held Encompass Health as of Q4 2023.

Based on Legato Capital Management's 13F filing for Q4 2023, filed 16 Jan 2024.